Les Sulewski
Stock Analyst at Truist Securities
(0.79)
# 3,917
Out of 4,974 analysts
12
Total ratings
45.45%
Success rate
-25.96%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Les Sulewski
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TEVA Teva Pharmaceutical Industries | Initiates: Buy | $25 | $18.95 | +31.93% | 1 | May 28, 2025 | |
| PCRX Pacira BioSciences | Upgrades: Hold | $8 → $25 | $26.45 | -5.48% | 6 | Jan 30, 2025 | |
| AMRX Amneal Pharmaceuticals | Maintains: Buy | $10 → $12 | $9.62 | +24.74% | 3 | Oct 2, 2024 | |
| COLL Collegium Pharmaceutical | Maintains: Buy | $40 → $42 | $38.37 | +9.46% | 2 | Aug 9, 2024 |
Teva Pharmaceutical Industries
May 28, 2025
Initiates: Buy
Price Target: $25
Current: $18.95
Upside: +31.93%
Pacira BioSciences
Jan 30, 2025
Upgrades: Hold
Price Target: $8 → $25
Current: $26.45
Upside: -5.48%
Amneal Pharmaceuticals
Oct 2, 2024
Maintains: Buy
Price Target: $10 → $12
Current: $9.62
Upside: +24.74%
Collegium Pharmaceutical
Aug 9, 2024
Maintains: Buy
Price Target: $40 → $42
Current: $38.37
Upside: +9.46%